$89.9 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 120 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 23.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
STJ | Buy | ST JUDE MED INC | $6,015,000 | -12.7% | 95,338 | +1.1% | 6.69% | +10.6% |
RMTI | Buy | ROCKWELL MED INC | $3,763,000 | -51.8% | 488,050 | +0.9% | 4.19% | -38.9% |
AXGN | Buy | AXOGEN INC | $2,730,000 | +37.3% | 662,700 | +4.7% | 3.04% | +73.9% |
CSII | Buy | CARDIOVASCULAR SYS INC DEL | $2,310,000 | -10.9% | 145,850 | +48.8% | 2.57% | +12.9% |
SVU | Buy | SUPERVALU INC | $1,866,000 | -9.3% | 259,900 | +2.2% | 2.08% | +14.9% |
DEPO | Buy | DEPOMED INC | $1,865,000 | -11.7% | 98,950 | +0.5% | 2.08% | +11.8% |
LLY | Buy | LILLY ELI & CO | $1,699,000 | +0.8% | 20,300 | +0.5% | 1.89% | +27.6% |
PIP | Buy | PHARMATHENE INC | $1,617,000 | -26.0% | 1,215,600 | +0.2% | 1.80% | -6.2% |
CGNT | Buy | COGENTIX MED INC | $1,543,000 | -9.4% | 1,244,597 | +18.4% | 1.72% | +14.8% |
JCPNQ | Buy | PENNEY J C INC | $1,407,000 | +12.7% | 151,400 | +2.7% | 1.56% | +42.8% |
SPSC | Buy | SPS COMM INC | $1,198,000 | +13.4% | 17,650 | +10.0% | 1.33% | +43.8% |
BEAT | New | BIOTELEMETRY INC | $1,144,000 | – | 93,450 | +100.0% | 1.27% | – |
ABBV | Buy | ABBVIE INC | $1,011,000 | -15.6% | 18,575 | +4.2% | 1.12% | +6.9% |
ETRM | New | ENTEROMEDICS INC | $972,000 | – | 3,738,361 | +100.0% | 1.08% | – |
ABT | Buy | ABBOTT LABS | $930,000 | -16.6% | 23,125 | +1.8% | 1.04% | +5.7% |
JCI | Buy | JOHNSON CTLS INC | $906,000 | -15.3% | 21,900 | +1.4% | 1.01% | +7.2% |
OUTR | Buy | OUTERWALL INC | $814,000 | -24.7% | 14,300 | +0.7% | 0.91% | -4.5% |
EXPD | Buy | EXPEDITORS INTL WASH INC | $760,000 | +10.6% | 16,150 | +8.4% | 0.85% | +40.3% |
RH | Buy | RESTORATION HARDWARE HLDGS I | $649,000 | +1.6% | 6,950 | +6.1% | 0.72% | +28.7% |
T | New | AT & T INC | $598,000 | – | 18,362 | +100.0% | 0.66% | – |
GB | Buy | GREATBATCH INC | $592,000 | +22.1% | 10,500 | +16.7% | 0.66% | +54.7% |
GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $558,000 | 0.0% | 14,500 | +8.2% | 0.62% | +26.7% |
BCSPRACL | New | BARCLAYS BANK PLCsp adr 7.1%pf3 | $486,000 | – | 19,000 | +100.0% | 0.54% | – |
EPAY | Buy | BOTTOMLINE TECH DEL INC | $463,000 | -4.1% | 18,500 | +6.6% | 0.52% | +21.5% |
CYTX | Buy | CYTORI THERAPEUTICS INC | $440,000 | -28.5% | 1,294,321 | +17.3% | 0.49% | -9.3% |
QUMU | Buy | QUMU CORP | $435,000 | +26.1% | 112,900 | +169.5% | 0.48% | +59.7% |
NVDA | Buy | NVIDIA CORP | $418,000 | +25.1% | 16,975 | +2.3% | 0.46% | +58.7% |
DAKPQ | Buy | DAKOTA PLAINS HLDGS INC | $382,000 | -30.3% | 477,500 | +3.6% | 0.42% | -11.6% |
MSFT | Buy | MICROSOFT CORP | $379,000 | +27.2% | 8,560 | +26.6% | 0.42% | +61.1% |
VRML | New | VERMILLION INC | $367,000 | – | 183,500 | +100.0% | 0.41% | – |
GEOS | Buy | GEOSPACE TECHNOLOGIES CORP | $363,000 | -29.7% | 26,250 | +17.2% | 0.40% | -10.8% |
HNSN | New | HANSEN MEDICAL INC | $331,000 | – | 88,160 | +100.0% | 0.37% | – |
TEAR | Buy | TEARLAB CORP | $321,000 | +16.3% | 159,750 | +17.0% | 0.36% | +47.5% |
SPDC | Buy | SPEED COMM INC | $277,000 | +9.9% | 1,430,000 | +59.0% | 0.31% | +39.4% |
DD | Buy | DU PONT E I DE NEMOURS & CO | $237,000 | -16.5% | 4,910 | +10.7% | 0.26% | +6.0% |
SUMR | Buy | SUMMER INFANT INC | $132,000 | +25.7% | 77,000 | +48.1% | 0.15% | +59.8% |
GDEN | New | GOLDEN ENTMT INC | $95,000 | – | 10,500 | +100.0% | 0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-09
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEOGENOMICS INC | 41 | Q3 2023 | 7.8% |
LILY ELI & CO | 41 | Q3 2023 | 6.9% |
PFIZER INC | 41 | Q3 2023 | 2.9% |
ATTUNITY LTD | 41 | Q3 2023 | 3.6% |
EXPEDITORS INTL WASH INC | 41 | Q3 2023 | 2.3% |
CVS HEALTH CORP | 41 | Q3 2023 | 1.6% |
DONALDSON INC | 41 | Q3 2023 | 1.3% |
VERIZON COMMUNICATIONS INC | 41 | Q3 2023 | 1.0% |
US BANCORP DEL | 41 | Q3 2023 | 0.8% |
BAXTER INTL INC | 40 | Q3 2023 | 14.1% |
View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
BIOLASE, INC | May 15, 2023 | 689,196 | 2.1% |
FlexShopper, Inc. | February 09, 2023 | 1,281,460 | 5.9% |
Avinger Inc | February 14, 2020 | 891,761 | 5.2% |
Black Ridge Oil & Gas, Inc. | February 15, 2019 | 30,021,032 | 6.3% |
CANCER GENETICS, INC | February 15, 2019 | 1,135,250 | 4.0% |
TearLab Corp | February 15, 2019 | 1,666,294 | 13.1% |
Xtant Medical Holdings, Inc. | February 15, 2019 | 684,408 | 3.6% |
TearLab Corp | January 26, 2018 | 4,300,655 | 40.1% |
BIO KEY INTERNATIONAL INC | February 09, 2017 | 274,900 | 4.4% |
EnteroMedics Inc | February 09, 2017 | 1,455 | 0.0% |
View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-09 |
13F-HR | 2024-01-22 |
13F-HR | 2023-11-02 |
13F-HR | 2023-07-21 |
SC 13G/A | 2023-05-15 |
13F-HR | 2023-05-09 |
SC 13G/A | 2023-02-09 |
SC 13G | 2023-02-09 |
13F-HR | 2023-01-26 |
13F-HR | 2022-10-24 |
View PERKINS CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.